This inventor holds 1 USPTO granted patent. Top assignee: Wakunaga Phaemaceutical Co., Ltd.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Takao Tanaka: Innovator in Lipid Metabolism Diagnostics
Introduction
Takao Tanaka is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of medical diagnostics, particularly in understanding lipid metabolism abnormalities. His work has the potential to impact the diagnosis and treatment of various diseases.
Latest Patents
Tanaka holds a patent for the CD36 mutant gene and methods for diagnosing diseases caused by abnormal lipid metabolism, along with diagnostic kits for these conditions. This invention provides valuable tools for identifying diseases linked to lipid metabolism issues, enhancing the ability to diagnose and manage such health concerns.
Career Highlights
Throughout his career, Takao Tanaka has been associated with Wakunaga Pharmaceutical Co., Ltd. His innovative approach and dedication to research have positioned him as a key figure in the pharmaceutical industry. His work continues to influence advancements in medical diagnostics.
Collaborations
Tanaka has collaborated with notable colleagues, including Takanori Oka and Akio Yamane. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Takao Tanaka's contributions to the field of lipid metabolism diagnostics exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile